This site is intended for healthcare professionals only
A “thorough review” by the Medicines and Healthcare products Regulatory Agency (MHRA) has found that evidence “does not support” a link between suicidal ideation and diabetes and weight management drug semaglutide.
The MHRA “has concluded that the available evidence does not establish a causal relationship between Glucagon-Like Peptide-1 (GLP-1) receptor agonists and suicidal behaviour, suicidal ideation, self-injury and depression”, it yesterday (September 4) announced.
Register to gain full access to C+D and C+D Community content
Already registered?
Already registered?
Chair of the National Pharmacy Association (NPA) Nick Kaye has said that he “definitely wouldn't be thinking about a U-turn” on collective action, amid “real anger” over a lack of April cash.
The pharmacy hypertension service specification is set to be updated to exclude patients who request “frequent measurement of their blood pressure”.
CPE is recruiting a new independent chair to “provide strategic leadership” – the position pays £50k a year and only requires a “time commitment” of 3-4 working days per calendar month.
The government has announced an expansion to and fresh payment structure for the new medicine service (NMS) to “boost mental health support in the community”.
The government has announced that it will expand the pharmacy contraception service (PCS), making the morning-after pill “available free of charge” at pharmacies in England.
